Prevention of congenital Chagas through treatment of girls and women of childbearing age
- PMID: 25993401
- PMCID: PMC4501414
- DOI: 10.1590/0074-02760140347
Prevention of congenital Chagas through treatment of girls and women of childbearing age
Abstract
It is currently unknown whether treatment of Chagas disease decreases the risk of congenital transmission from previously treated mothers to their infants. In a cohort of women with Chagas disease previously treated with benznidazole, no congenital transmission of the disease was observed in their newborns. This finding provides support for the treatment of Chagas disease as early as possible.
References
- 
    - Altcheh J. La enfermedad de Chagas a 100 años de su descubrimiento. Arch Argent Pediatr. 2010;108:4–5. - PubMed
 
- 
    - Altcheh J, Biancardi M, Lapeña A, Ballering G, Freilij H. Enfermedad de Chagas congénita, experiencia del Hospital de Niños Dr Ricardo Gutiérrez, Buenos Aires. Rev Soc Bras Med Trop. 2005;38:41–45. - PubMed
 
- 
    - Altcheh J, Bisio M, Moscatelli G, Moroni S, García-Bournissen F, Schijman A, Ballering G, Ribeiro I. PCR as a marker of cure in pediatric Chagas disease; 32nd Annual Meeting of the European Society for Pediatric Infectious Diseases; 2014 May 6-10; Dublin. 2014. Proceedings of the. Abstract 98. Available from:
 
- 
    - Altcheh J, Moscatelli G, Moroni S, García-Bournissen F, Freilij H. Adverse events after the use of benznidazole in infants and children with Chagas disease. Pediatrics. 2011;127:e212–e218. - PubMed
 
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        